Scienture Holdings, Inc. SEC filings SCNX
Scienture Holdings, Inc. has 507 filings in SEC EDGAR's recent list, going back to Jun 15, 2007. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Nov 7, 2025 | — |
| 424B5 | Prospectus supplement | Oct 24, 2025 | — |
| 424B3 | Prospectus | Oct 14, 2025 | — |
| 424B5 | Prospectus supplement | Sep 19, 2025 | — |
| 424B3 | Prospectus | Aug 27, 2025 | — |
| S-3 | Shelf registration | Aug 25, 2025 | — |
| 424B5 | Prospectus supplement | Aug 15, 2025 | — |
| S-3 | Shelf registration | Aug 1, 2025 | — |
| POS AM | Filing | Jun 16, 2025 | — |
| 424B3 | Prospectus | Apr 24, 2025 | — |
| 424B3 | Prospectus | Apr 11, 2025 | — |
| S-1 | Registration statement | Apr 4, 2025 | — |
| 424B3 | Prospectus | Feb 24, 2025 | — |
| S-1/A | Amended registration statement | Feb 6, 2025 | — |
| S-1/A | Amended registration statement | Jan 30, 2025 | — |
| S-1/A | Amended registration statement | Jan 14, 2025 | — |
| S-1 | Registration statement | Dec 3, 2024 | — |
| S-1 | Registration statement | Apr 17, 2023 | — |
| 424B3 | Prospectus | Dec 8, 2022 | — |
| S-1 | Registration statement | Nov 28, 2022 | — |
| 424B5 | Prospectus supplement | Oct 6, 2022 | — |
| 424B5 | Prospectus supplement | Aug 23, 2022 | — |
| S-3 | Shelf registration | Jul 29, 2022 | — |
| 424B5 | Prospectus supplement | Dec 6, 2021 | — |
| 424B5 | Prospectus supplement | Aug 6, 2021 | — |
| 424B3 | Prospectus | Sep 4, 2020 | — |
| S-3 | Shelf registration | Aug 28, 2020 | — |
| S-8 | Employee stock plan registration | Aug 14, 2020 | — |
| 424B4 | Prospectus | Feb 14, 2020 | — |
| S-1/A | Amended registration statement | Feb 12, 2020 | — |
| S-1/A | Amended registration statement | Feb 3, 2020 | — |
| S-1/A | Amended registration statement | Jan 27, 2020 | — |
| S-1 | Registration statement | Dec 17, 2019 | — |
| 424B3 | Prospectus | Nov 19, 2019 | — |
| S-1/A | Amended registration statement | Nov 8, 2019 | — |
| S-1 | Registration statement | Oct 15, 2019 | — |
| 424B3 | Prospectus | Jul 2, 2019 | — |
| S-1/A | Amended registration statement | Jun 20, 2019 | — |
| S-1/A | Amended registration statement | Jun 14, 2019 | — |
| S-1 | Registration statement | May 6, 2019 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SCNX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Commack, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1382574
- Former names
- TRxADE HEALTH, INC (until Aug 28, 2024); TRXADE GROUP, INC. (until May 28, 2021); XCELLINK INTERNATIONAL INC. (until Jan 31, 2014); Bluebird Exploration Co. (until Dec 10, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.